ADIL - נפח מכירות חזוי Adial Pharmaceuticals

The projected sales volume for Adial Pharmaceuticals (ADIL) on GURU.Markets reflects growth driven by FDA approval of AD04 drug trials. The company relies on unique, patent-protected genetic addiction therapy, yet faces marketing budget deficits and regulatory barriers. The current value of this metric is 0.00, highlighting a revision of the fundamental revenue potential for Adial Pharmaceuticals.

This indicator provides an objective assessment of expected revenue, stripped of market noise and emotional factors. By analyzing the projected sales volume, an investor obtains independent confirmation of the asset's financial stability. The metric is based on a daily calculation of equilibrium points, revealing hidden vulnerabilities in revenue modeling. For Adial Pharmaceuticals (ADIL), this figure is critically important, as future cash flows depend directly on clinical trial outcomes. The indicator's stability, coupled with available cash, helps manage the risks associated with upcoming licensing agreements.